Browsing by Contributors Bruserud, Øystein

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
آ ب پ ت ث ج چ ح خ د ذ ر ز ژ س ش ص ض ط ظ ع غ ف ق ک گ ل م ن و ه ی
Showing results 1 to 13 of 13
PreviewIssue DateTitleContributor(s)
10-Apr-2006Correlation analysis of two-dimensional gel electrophoretic protein patterns and biological variablesVan Belle, Werner; Ånensen, Nina; Haaland, Ingvild; Bruserud, Øystein; Høgda, Kjell-Arild; Gjertsen, Bjørn Tore
2013Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosisGausdal, Gro; Wergeland, Anita; Skavland, Jørn; Nguyen, Eric; Pendino, Frédéric; Rouhee, Nazanin; McCormack, Emmet; Herfindal, Lars; Kleppe, Rune; Havemann, Ursula; Schwede, Frank; Bruserud, Øystein; Gjertsen, Bjørn Tore; Lanotte, Michel; Ségal-Bendirdjian, Evelyne; Døskeland, Stein Ove
11-Jul-2013Distinct single cell signal transduction signatures in leukocyte subsets stimulated with khat extract, amphetamine-like cathinone, cathine or norephedrineBredholt, Therese; Ersvær, Elisabeth; Erikstein, Bjarte Skoe; Sulen, André; Reikvam, Håkon; Aarstad, Hans Jørgen; Johannessen, Anne Christine; Vintermyr, Olav Karsten; Bruserud, Øystein; Gjertsen, Bjørn Tore
2008Effects of Benzene on human hematopoiesisKirkeleit, Jorunn; Riise, Trond; Gjertsen, Bjørn Tore; Moen, Bente E.; Bråtveit, Magne; Bruserud, Øystein
5-Mar-2009Genes of cell-cell interactions, chemotherapy detoxification and apoptosis are induced during chemotherapy of acute myeloid leukemiaØyan, Anne Margrete; Ånensen, Nina; Bø, Trond Hellem; Stordrange, Laila; Jonassen, Inge; Bruserud, Øystein; Kalland, Karl-Henning; Gjertsen, Bjørn Tore
30-Jul-2013Histone deacetylase inhibition in the treatment of acute myeloid leukemia: the effects of valproic acid on leukemic cells, and the clinical and experimental evidence for combining valproic acid with other antileukemic agentsFredly, Hanne Kristin; Gjertsen, Bjørn Tore; Bruserud, Øystein
9-Jul-2010Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cellsErsvær, Elisabeth; Liseth, Knut; Skavland, Jørn; Gjertsen, Bjørn Tore; Bruserud, Øystein
21-May-2014Molecular mechanisms of nutlin-3 involve acetylation of p53, histones and heat shock proteins in acute myeloid leukemiaHaaland, Ingvild; Opsahl, Jill Anette; Berven, Frode S.; Reikvam, Håkon; Fredly, Hanne Kristin; Haugse, Ragnhild; Thiede, Bernd; McCormack, Emmet; Lain, Sonia; Bruserud, Øystein; Gjertsen, Bjørn Tore
2007Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cellsWergeland, Line; Sjøholt, Gry; Haaland, Ingvild; Hovland, Randi; Bruserud, Øystein; Gjertsen, Bjørn Tore
30-Sep-2014Systemic levels of the endothelium-derived soluble adhesion molecules endocan and E-selectin in patients with suspected deep vein thrombosisMosevoll, Knut Anders; Lindås, Roald; Wendelbo, Øystein; Bruserud, Øystein; Reikvam, Håkon
1-Aug-2013The combination of valproic acid, all-trans retinoic acid and low-dose cytarabine as disease-stabilizing treatment in acute myeloid leukemiaFredly, Hanne Kristin; Ersvær, Elisabeth; Kittang, Astrid O.; Tsykunova, Galina; Gjertsen, Bjørn Tore; Bruserud, Øystein
2007The immunological dilemma: Cellular innate and adaptive immune response versus human acute myeloid leukemiaErsvær, Elisabeth; Olsnes, Astrid M.; Bruserud, Øystein
14-Nov-2013The role of arginine and arginine-metabolizing enzymes during Giardia - host cell interactions in vitroStadelmann, Britta; Hanevik, Kurt; Andersson, Mattias; Bruserud, Øystein; Svärd, Staffan G.